5US Department of Health and Human Services, FDA. Development and Use of Risk Minimization Action Plans ( Risk- MAP Guidance). March 2005, Clinical Medical.
6Admad SR, Goetsch RA, Marks NS. Spontaneous Reporting in the United States [A]. in: Strom BL. Pharmacoepidemiology[ M]. Wiley,135-159.
7Burns W. WHO launches taskforce to fight counterfeit drugs [ J ]. Bulletin of the World Health Organization, 2006,84 (9) :6894590.
8Quick JD, Hogerzeil HV. Twenty-five years of essential medicines [ J ]. Bulletin of the World Health Organization, 2002, 80 (11) :913-914.
9Holloway K, Green T. Drug and Therapeutics Committees. A Practical Guide. Department of Essential Drugs and Medicines Policy. WHO 2003.
10IOM Report: More Bad News About Medication Errors[N]. The National Academics News,2006-09-14.
